Hansard

PE2024, which has been lodged by Cael Scott, calls on the Parliament to urge the Scottish Government to create a national public information programme to raise awareness of the impacts of the use of steroids, selective androgen receptor modulators and other performance-enhancing drugs. It makes the case that that programme should have a particular focus on the impact of such products on young people aged 16 to 25, and that work should be done with community learning and development practitioners, gyms and community coaches to raise awareness of the issue. It also asks that a public health campaign be developed to highlight the negative impacts of PEDs and to encourage regular health check-ups for users, and that a screening programme be developed to allow users to test the safety of their PEDs. We last considered the petition on 6 September 2023, when we agreed to write to UK Anti-Doping, Anabolic Steroids UK and the Scottish Drugs Forum, as well as the Scottish Government. The Scottish Government has responded by providing the terms of reference for the early interventions for children and young people working group, which, it notes, “will be guided every step of the way by the experiences of young people whose lives have been affected by alcohol and drug use and the front line services who support them.” The response also lists the organisations that are members of the working group. In its response, UK Anti-Doping draws our attention to its 2019 report on image and performance-enhancing drugs, which showed that the use of IPEDs extends beyond cheating in sport and is a significant public health issue. It is UK Anti-Doping’s view that structural arrangements to establish cross-agency working are needed in order to tackle the wider public health concerns that exist in relation to IPED use. The Scottish Drugs Forum would welcome and actively support any national initiative that was focused on reducing the risks and harms associated with IPEDs. The forum suggests that a national campaign should be accompanied by the provision of adequate services, such as blood testing and other health checks, to reduce harms. We have also received a response from the petitioner, in which they share their analysis of a series of freedom of information requests to regional health boards across Scotland on the costs and prevalence of, and existing support for, IPED use. Do members have any comments or suggestions for action, given the robust responses that we have received?